In the Media | March 06, 2018

New Canadian research aims for tailored treatment of pancreatic cancer

Related News & Events

Research Highlight|December 14, 2023

New findings reveal novel biomarker can predict success of immunotherapy

A team of Montreal-based researchers discovered a novel biomarker that can help them predict which patients are most likely to benefit from immune che...

Research Highlight|November 01, 2021

EPPIC Researchers present in first Marathon of Hope Cancer Centres Network Seminar Series

Researchers from TFRI's Enhanced Pancreatic Cancer Profiling for Individualized Care presented during the first event of the Marathon of Hope Cancer C...

Research Highlight|June 08, 2021

Study identifies biomarkers that predict which pancreatic cancer patients with germline BRCA mutations will benefit from personalized therapies using platinums and PARP inhibitors

A new study published in Clinical Cancer Research (October 2020) provides insight into which pancreatic cancer patients with germline BRCA mutations w...

Research Highlight|December 14, 2020

Study reveals unique mutational pattern in patients with early-onset pancreatic cancer

TFRI-funded researchers have found that patients with early-onset pancreatic cancer have a distinct mutational pattern in a gene called CDKN2A. This d...

Research Highlight|April 20, 2020

Pancreatic cancer researchers encouraged by new T-cell finding that identifies patients with hallmarks of an antitumour response

A small subset of patients with pancreatic cancer exhibit a T-cell inflamed profile, a finding that could open the door for the potential use of immun...

Research Highlight|January 14, 2020

New Canadian research aims for tailored treatment of pancreatic cancer

Funding Opportunities

Our Research

Impact

About Cancer

Updates

About Us

Contact